All In Biotech

Drug Trial Radar · NCT05852938

A Study of Zigakibart in Adults With IgA Nephropathy

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy (The BEYOND Study)

Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 383 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

383

Actual

Start

Jul 6, 2023

Primary completion

Aug 10, 2027

Study completion Jan 25, 2028

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
May 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy

Conditions

  • IgA Nephropathy
  • Immunoglobulin A Nephropathy

Interventions

  • BION-1301Drug

    BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks.

  • PlaceboDrug

    Placebo - PFS subcutaneous administration every 2 weeks for 104 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in eGFRTime frame: Baseline and 104 weeks or approximately 2 years

Locations

200 sites in 23 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham: The Kirklin Clinic

    Birmingham, Alabama

  • Nephrology Consultants, LLC

    Huntsville, Alabama

  • University of California, San Francisco

    San Francisco, California

  • Valiance Clinical Research

    South Gate, California

  • University of Colorado Hospital

    Aurora, Colorado

  • Denver Nephrology Research Division

    Denver, Colorado

  • Vida Medical Centers - Pembroke Pines

    Pembroke Pines, Florida

  • NorthShore University HealthSystem

    Evanston, Illinois

  • Nephrology Associales of Northern Illinois and Indiana

    Hinsdale, Illinois

  • Nephrology Associates of Northern Illinois and Indiana - 7836 W Jefferson Blvd

    Fort Wayne, Indiana

  • University Of Iowa Hospitals And Clinics

    Iowa City, Iowa

  • Intermed Consultants

    Edina, Minnesota

  • Capital District Renal Physicians

    Clifton Park, New York

  • Nephrology Associates PC - Flushing

    Flushing, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • University of Cincinnati College of Medicine - 231 Albert Sabin Way

    Cincinnati, Ohio

  • Cleveland Clinic-9500 Euclid Ave

    Cleveland, Ohio

  • OHSU - Oregon Clinical and Translational Research Institute

    Portland, Oregon

  • Northeast Clinical Research Center, LLC

    Bethlehem, Pennsylvania

  • Columbia Nephrology Associates , P.A. - Columbia

    Columbia, South Carolina

  • Knoxville Kidney Center, PLLC - Frenova F1

    Knoxville, Tennessee

  • Dallas Renal Group - 1411 N Beckley Ave

    Dallas, Texas

  • Dallas Renal Group - Waxachie - 2460 N. I-35

    Dallas, Texas

  • DaVita Clinical Research

    El Paso, Texas

  • University of Texas MD Anderson Cancer Center-1155 Pressler

    Houston, Texas

  • East Texas Nephrology Associates

    Lufkin, Texas

  • Nephrology Associates of Northern Virginia-8501 Arlington Blvd

    Fairfax, Virginia

  • Swedish Center for Comprehensive Care

    Seattle, Washington

  • Novartis Investigative Site

    Buenos Aires, Argentina

  • Novartis Investigative Site

    La Plata, Buenos Aires, Argentina

  • Novartis Investigative Site

    Catamarca, Catamarca Province, Argentina

  • Novartis Investigative Site

    Barracas, Ciudad Autónoma de BuenosAires, Argentina

  • Novartis Investigative Site

    Rosario, Santa Fe Province, Argentina

  • Novartis Investigative Site

    Santa Fe, Santa Fe Province, Argentina

  • Novartis Investigative Site

    Gosford, New South Wales, Australia

  • Novartis Investigative Site

    Kogarah, New South Wales, Australia

  • Novartis Investigative Site

    Liverpool, New South Wales, Australia

  • Novartis Investigative Site

    Penrith, New South Wales, Australia

  • Novartis Investigative Site

    St Leonards, New South Wales, Australia

  • Novartis Investigative Site

    Cairns North, Queensland, Australia

Showing 40 of 200 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.